Allerg

Novartis to Shire Said to Weigh Bids for ThromboGenics
Bloomberg
Mon, 04/14/14 - 06:49 pm
Shire
ThromboGenics
Novartis
Roche
Valeant Pharmaceuticals
Regeneron
Allerg